The most prevalent HPC1-associated mutations in RNase L, R462Q and E265X, enhanced AR signaling and cell migration and our studies identify a novel role of RNase L as a prostate cancer susceptibility gene. The gene discussed is AR; the disease is prostate carcinoma.